Click on headlines below to download research

Resilient business model in a challenging market
Thrace Group | 21/06/2023

Thrace Group’s Q123 results highlight continued growth in underlying adjusted EBITDA (excluding personal protective equipment (PPE) related products),…

...read more

Demonstrable core growth as COVID-19 subsides
Thrace Group | 13/04/2023

Thrace Plastics’ FY22e core product PBT (excluding the c €5m pandemic-related personal protective equipment (PPE) boost and one-off financial…

...read more

Maintaining a steady course
Thrace Plastics | 06/12/2021

Thrace delivered another strong profit contribution in Q3, even after the expected slowdown in sales volumes to the medical subsector. This ongoing sector…

...read more

Investing for the future
Thrace Plastics | 18/10/2021

Thrace continued to successfully service high medical sector demand and support customers elsewhere in the face of input cost pressures in H121. Cash generation…

...read more